×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
ESMO Asia Virtual Oncology Week 2021
Final Programme PDF
Advanced Search
17.11.2021
18.11.2021
19.11.2021
20.11.2021
21.11.2021
22.11.2021
23.11.2021
ESMO Asia Highlights of the Year
ESMO Virtual Plenary
Industry Satellite Symposium
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
Channel 1
15:30(1h 15m)
Current standards and practice changing studies in lower gastrointestinal cancers
14:00(1h 15m)
Current standards and practice changing studies in upper gastrointestinal cancer
19:00(1h 15m)
ESMO Virtual Plenary - ORIENT-31: Phase III study of sintilimab with or without IBI305 plus chemotherapy in patients with EGFR mutated nonsquamous NSCLC who progressed after EGFR-TKI therapy
12:00(1h 30m)
Pfizer Corporation Hong Kong Limited - Optimising treatment in ALK+ NSCLC: Debate and Ongoing Conversations
17:00(1h 30m)
Pfizer Corporation Hong Kong Limited - Transforming care in ER+ HER2- metastatic breast cancer with a focus on CDK4/6 inhibition
Channel 2
12:00(1h 30m)
Boehringer Ingelheim - Expert Perspectives in Navigating the Evolving Treatment Landscape in Advanced NSCLC
15:30(1h 15m)
Current standards and practice changing studies in genitourinary cancers
14:00(1h 15m)
Current standards and practice changing studies in thoracic cancers
17:00(1h 30m)
Merck KGaA – Pfizer Oncology - Bringing Patient Care to Life in Urothelial and Renal Cell Carcinomas
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events